Expression, purification and characterization of the Hepatitis B virus entire envelope large protein in Pichia pastoris

Protein Expression and Purification

Volumn 49, Issue 2, 2006, Pages 168-175

  Han, Xue ^a   Ye, Lin Bai ^a   Li, Bao zong ^a   Bo, Gao ^a   Cai, Wei jia ^a   Hong, Zheng ^a   She, Ying Long ^a   Li, Ye ^a   Kong, Ling Bao ^a   Wu, Zheng Hui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Fermentation; Hepatitis B virus (HBV); Large protein; Purification; Vaccine

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; L PROTEIN, HEPATITIS B VIRUS; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; DOSE RESPONSE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; PICHIA; RABBIT; TIME;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; PICHIA; RABBITS; RECOMBINANT PROTEINS; TIME FACTORS; VIRAL ENVELOPE PROTEINS;

EUKARYOTA; HEPATITIS B VIRUS; ORYCTOLAGUS CUNICULUS; PICHIA PASTORIS;

EID: 33748784854     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.05.002     Document Type: Article

References (30)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral Hepat. 11 (2004) 97-107
2. Karayiannis P. Hepatitis B virus: old, new and future approaches to antiviral treatment. J. Antimicrob. Chemother. 51 4 (2003) 761-785
3. Nevens F., Goubau P., and Van Eyken P. Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. Liver 13 (1993) 15-19
4. Perrillo R., Tamburro C., Regenstein F., et al. Low-dose, titratable interferon alpha in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology 109 (1995) 908-916
5. Liaw Y.F., Leung N.W., Chang T.T., et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology 119 1 (2000) 172-180
6. Doong S.L., Tsai C.H., and Schinazi R.F. Inhibition of the replication of hepatitis B virus in vitro by 20,30-dideoxy-30-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA 88 (1991) 8495-8499
7. Dienstag J.L., Perrillo R.P., Schiff E.R., et al. A preliminary trial for chronic hepatitis B infection. N. Engl. J. Med. 333 (1995) 1657-1661
8. Leung N. Treatment of chronic hepatitis B: case selection and duration of therapy. J. Gastroenterol. Hepatol. 17 4 (2002) 409-414
9. ul-Haq N., Hasnain S.S., Umar M., et al. Immunogenicity of 10 and 20 microgram hepatitis B vaccine in a two-dose schedule. Vaccine 21 (2003) 3179-3185
10. World Health Organization. Hepatitis B. World Health Organization Fact Sheet 204 (Revised October 2000). WHO Web site. 2000. .
11. Neurath A.R., Seto B., and Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7 (1989) 234-236
12. Hong H.J., Ryu C.J., Hur H., et al. In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees [J]. Virology 318 1 (2004) 134-141
13. Milich D.R. Immunological response to pre-S antigens of the hepatitis B virus. Viral Immunol. 1 (1987) 83-96
14. Neurath A.R., and Kent S.B.H. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46 (1986) 429-436
15. Neurath A.R., Kent S.B.H., Parker K., et al. Antibodies to a synthetic peptide from the preS120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 4 (1986) 35-37
16. Shouval D., Ilan Y., and Adler R. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines. Vaccine 12 (1994) 1453-1459
17. Cereghino J.L., and Cregg J.M. Heterologous protein expression in the methylotrophic yeast Pichia pastor. Microbiol. Rev. 24 (2000) 45-66
18. Pichia Expression Kit: Protein Expression A Manual of Methods for Expression of Recombinant Proteins in Pichia pastoris, Invitrogen Corp., 3985 B Sorrento Valley Blvd., San Diego, CA 92121.
19. Wegner E.H. Biochemical conversions by yeast fermentation at high cell densities. US Patent 441 (1983) 4329
20. Tschopp J.F., Brust P.E., and Cregg J.M. Expression of the lacZ gene from two recombinant methanol-regulated promoters in Pichia pastoris. Nucleic Acids Res. 15 (1987) 3859-3876
21. Hardy E., Martinez E., and Diago D. Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. J. Biotechnol. 77 (2000) 157-167
22. ul-Haq N., Hasnain S.S., and Umarc M. Immunogenicity of 10 and 20 _g hepatitis B vaccine in a two-dose schedule. Vaccine 21 (2003) 3179-3185
23. Kuroda S., Otaka S., Miyazaki T., et al. Hepatitis B virus envelope L protein particles eynthesis and assembly in saccharomyces cerevisae, purification and characterization. J. Biol. Chem. 25 (1992) 1953-1961
24. Yamada T., Iwabuki H., Kanno T., et al. Physicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1_pre-S2_S) protein. Vaccine 19 (2001) 3154-3163
25. Tiollais P., Christine P., and Dejean A. The hepatitis B virus. Nature 317 (1985) 489-495
26. Hui J.Y., Li G.D., and Kong Y.Y. Expression and characterization of chimeric hepatitis B surface antigen particles carrying preS epitopes. J. Biotechnol. 72 (1999) 49-59
27. Holzer G.W., Mayrhofer J., and Leitner J. Overexpression of hepatitis B virus surface antigens including the preS1 region in a serum-free Chinese hamster ovary cell line. Protein Express. Purif. 29 (2003) 58-69
28. Trevisan A., Gudat F., Guggenheim R., et al. Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy. Hepatology 2 (1982) 832-839
29. D.R. Higgins, J.M. Cregg. Pichia Protocols, Humana Press.
30. Werten M.W.T., Van den Bosch T.J., and Wind R.D. High2 yield secretion of recombinant gelatins by pichia pastoris [J]. Yeast 15 11 (1999) 1087-1096